Cargando…
Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression
The long noncoding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 (NNT-AS1) is a key malignancy regulator in a variety of human cancers. In this study, we first measured the expression of NNT-AS1 in bladder cancer and examined its role in cancer progression. The mechanisms behind the o...
Autores principales: | Wu, Deyao, Zhang, Tielong, Wang, Jie, Zhou, Jian, Pan, Huixing, Qu, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949093/ https://www.ncbi.nlm.nih.gov/pubmed/31848324 http://dx.doi.org/10.18632/aging.102591 |
Ejemplares similares
-
Long noncoding RNA TTN-AS1 enhances the malignant characteristics of osteosarcoma by acting as a competing endogenous RNA on microRNA-376a thereby upregulating dickkopf-1
por: Li, Shenglong, et al.
Publicado: (2019) -
LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis
por: Liu, Yanjie, et al.
Publicado: (2020) -
Long noncoding RNA LINC00324 promotes retinoblastoma progression by acting as a competing endogenous RNA for microRNA-769-5p, thereby increasing STAT3 expression
por: Dong, Yi, et al.
Publicado: (2020) -
lnCeDB: Database of Human Long Noncoding RNA Acting as Competing Endogenous RNA
por: Das, Shaoli, et al.
Publicado: (2014) -
NNT-AS1 modulates prostate cancer cell proliferation, apoptosis and migration through miR-496/DDIT4 axis
por: Yao, Changlei, et al.
Publicado: (2020)